June 01, 2020
Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants.
January 27, 2020
Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed.
November 15, 2019
First and currently only biological targeting P-selectin.
October 09, 2019
Also indciated to control bleeding and perioperative management.
July 29, 2019
Black box warns of increased risk of blood clots and death.
June 14, 2019
Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.
Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.
May 24, 2019
The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.
Overestimating the bleeding risk of anticoagulants may lead to poor compliance.
May 16, 2019
Fragmin, a low-molecular-weight heparin dalteparin sodium injection, was approved for symptomatic venous thromboembolism.
April 22, 2019
Bleeding in patients with nonvalvular atrial fibrillation and coronary syndrome was reduced by apixaban versus vitamin K antagonists.
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
March 15, 2019
Study finds different anticoagulation treatment levels for patients with cognitive problems.
A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.
February 26, 2019
Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.
February 18, 2019
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
February 16, 2019
DOACs are as good as warfarin in preventing atrial fibrillation complications.
Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.
January 14, 2019
Black patients with atrial fibrillation are less likely to be treated with oral anticoagulants or DOACs.
January 11, 2019
The risk of gastrointestinal bleeding appears to be highest with rivaroxaban and lowest with apixaban, but is reduced by cotherapy with proton pump inhibitors.
